EXAGEN INC. Annual Costs and Expenses in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Exagen Inc. quarterly/annual Costs and Expenses history and growth rate from 2018 to 2023.
  • Exagen Inc. Costs and Expenses for the quarter ending September 30, 2024 was $17.2M, a 7.11% decline year-over-year.
  • Exagen Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $71.2M, a 15.1% decline year-over-year.
  • Exagen Inc. annual Costs and Expenses for 2023 was $75.4M, a 17.7% decline from 2022.
  • Exagen Inc. annual Costs and Expenses for 2022 was $91.6M, a 26.6% increase from 2021.
  • Exagen Inc. annual Costs and Expenses for 2021 was $72.4M, a 26.6% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $75.4M -$16.2M -17.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-18
2022 $91.6M +$19.2M +26.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-18
2021 $72.4M +$15.2M +26.6% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-20
2020 $57.2M +$7.47M +15% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-22
2019 $49.7M +$12.4M +33.1% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-16
2018 $37.3M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.